Last Posted: Jul 18, 2019
- Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy.
Limongelli Giuseppe et al. International journal of cardiology 2019 Jul - Analyzing and Reanalyzing the Genome: Findings from the MedSeq Project.
Machini Kalotina et al. American journal of human genetics 2019 Jul 105(1) 177-188 - Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
Maron Martin S et al. The American journal of medicine 2018 131(2) 200.e1-200.e8 - Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
Bauersachs Johann et al. European journal of heart failure 2019 Jun - Updates on the Genetic Paradigm in Heart Failure.
Rosenbaum Andrew N et al. Current treatment options in cardiovascular medicine 2019 Jun 21(8) 37 - A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy.
Catchpool Max et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Jun - Genetic Testing and Cascade Screening in Pediatric Long QT Syndrome and Hypertrophic Cardiomyopathy.
Knight Linda M et al. Heart rhythm 2019 Jun - Machine learning detection of obstructive hypertrophic cardiomyopathy using a wearable biosensor
EM Green et al, NPJ Digital Medicine, June 24, 2019 - Fabry disease in cardiology practice: Literature review and expert point of view.
Hagège Albert et al. Archives of cardiovascular diseases 2019 Apr 112(4) 278-287 - Family screening for hypertrophic cardiomyopathy: Is it time to change practical guidelines?
Lafreniere-Roula Myriam et al. European heart journal 2019 Jun
.png)
No hay comentarios:
Publicar un comentario